Aeglea BioTherapeutics
AGLE is nowSYRE

This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn MoreAeglea BioTherapeutics Stock News
View all

PRNewsWire •


Frequently Asked Questions (FAQ)
As of Jun 20, 2025, the market cap for AGLE stock is $905.91M
The current P/E ratio for AGLE stock is -4.95
The 52-week high for AGLE stock is $40.26. The current AGLE stock price $undefined is 100.00% below its 52-week high
The 52-week low for AGLE stock is $10.91. The current AGLE stock price $undefined has increased 100.00% from its 52-week low
No, the AGLE stock does not pay dividends to its shareholders
The target price for AGLE stock is $10.92 based on the average of what a group of analyst think AGLE stock could be worth at a future date. This is not a prediction by Public.com
How to buy AGLE stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in AGLE stock
Navigate to the Explore page. Then, type AGLE into the search bar. When you see AGLE stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased AGLE stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.